MedTrace Logo

Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

NCT02742064 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 899

Last updated 2018-07-17

No results posted yet for this study

Summary

The purpose of this study is to determine if a mobile sensing platform can passively and objectively detect the presence of clinically significant mood disorder symptomatology and symptom progression over time. Meeting this goal will allow for improved risk categorization, prediction of relapse, and measurement of disease progression in a lifetime prevalence population.

Conditions

Interventions

OTHER

Cogito Companion Mobile Phone Application

Sponsors & Collaborators

  • Massachusetts General Hospital

    collaborator OTHER

  • Partners HealthCare

    collaborator OTHER

  • Cogito Health Inc

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-12-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02742064 on ClinicalTrials.gov